Zanolimumab
Zanolimumab is a monoclonal antibody used in the treatment of certain types of cancer. It is specifically designed to target the CD4 receptor, which is found on the surface of T cells. By binding to this receptor, Zanolimumab can help to modulate the immune response and inhibit the growth of cancer cells.
Mechanism of Action
Zanolimumab works by targeting the CD4 receptor on T cells. The CD4 receptor is a glycoprotein that plays a crucial role in the immune system, particularly in the activation and regulation of T helper cells. By binding to CD4, Zanolimumab can interfere with the signaling pathways that promote the proliferation and survival of cancer cells. This can lead to the apoptosis (programmed cell death) of these cells and a reduction in tumor growth.
Clinical Uses
Zanolimumab has been investigated for use in the treatment of various types of cancer, including:
- Cutaneous T-cell lymphoma (CTCL)
- Peripheral T-cell lymphoma (PTCL)
Administration and Dosage
Zanolimumab is administered via intravenous infusion. The dosage and frequency of administration depend on the specific type of cancer being treated, the stage of the disease, and the patient's overall health. It is typically given in a clinical setting under the supervision of a healthcare professional.
Side Effects
Common side effects of Zanolimumab may include:
More severe side effects can occur and should be reported to a healthcare provider immediately. These may include severe allergic reactions, infections, and autoimmune reactions.
Research and Development
Zanolimumab is still under investigation in various clinical trials to determine its efficacy and safety in different cancer types. Ongoing research aims to better understand its mechanism of action and potential applications in oncology.
Related Pages
Categories
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
